Narrowing the gap between human and veterinary medicine.
AUSTIN, Texas, Feb. 9,
2012 /PRNewswire/ -- Bio-Medical Services has received USDA approval and
is now offering allergy drop immunotherapy as an alternative method for
administering allergy treatment for pet allergy patients. An in-house pilot
study is now underway, and preliminary findings are expected in the Fall of
2012.
"With
two options for immunotherapy, we can now better tailor treatment to the
temperament of the patient, and lifestyle of the pet owner," says Dr. Susan Keesee, Chief Scientific Officer at Bio-Medical
Services. "This will allow more patients to receive the allergy treatment
they need."
Bio-Medical
Services has been following the use of sublingual immunotherapy (allergy drops)
in humans as an alternative method for administering allergy treatment. Allergy
drops have been widely used in Europe, and are
now gaining favor in the U.S.; the first randomized trial in humans was
conducted in 1986 with proven efficacy. In a 2010 study conducted by the University of Wisconsin Veterinary School, sublingual
immunotherapy was shown to be effective in reducing symptoms and
allergen-specific IgE levels in dogs as well.(*Note 1) Allergy drops are now
being offered for canine allergy treatment by a select few veterinary teaching hospitals.
"Because of its proven efficacy in humans, and early success shown in
canines, we feel confident that sublingual immunotherapy is a safe and
effective treatment modality," says Keesee.
As
the gap between human and veterinary medicine narrows, Bio-Medical Services
remains in the forefront of serum allergy testing and treatment, providing the
most current and effective medicine for pet allergy patients. Bio-Medical
Services has achieved many "firsts" in the care of pet allergies.
They were the first to offer ELISA serum testing for canine, feline and equine
patients. In 2004, Bio-Medical services was the first to introduce the practice
of separating mold, mite and insect allergens into separate treatment from
pollen, fiber and epithelia allergens to the veterinary field – following the
convention used in human allergy treatment. Currently, Bio-Medical Services is
the only laboratory to offer five treatment protocols based on the patient's
age, weight, breed, species, and clinical history. And now with two options for
administering immunotherapy, patients receive even more customized and
effective care for pet allergies.
About
Bio-Medical Services:
Bio-Medical
Services is a veterinary reference laboratory specializing in allergy testing
and treatment for dogs, cats and horses. Founded in 1989, Bio-Medical Services
was the first laboratory to develop a commercial application for in
vitro allergy diagnostics in the veterinary industry. Bio-Medical
Services is based in Austin, TX. Visit www.bmslab.com to learn more.
*(NOTE
1) D.J DeBoer, 2010. Pilot trial of sublingual immunotherapy (SLIT) in
mite-sensitive atopic dogs. Veterinary Dermatology: Volume 21, Number 3, Page
325.
CONTACT:
Jenna Overbeck
Steel Brand Communications
800.681.8809 x102
direct: 512-354-1120
Jenna.Overbeck@Steelbranding.com
Steel Brand Communications
800.681.8809 x102
direct: 512-354-1120
Jenna.Overbeck@Steelbranding.com
Logo:
Send2Press.com/mediaboom/12-0208-bmserv_72dpi.jpg
This
release was issued on behalf of the above organization by Send2Press(R), a unit
of Neotrope(R). http://www.Send2Press.com
SOURCE
Bio-Medical Services
RELATED
LINKS
http://www.bmslab.com
http://www.bmslab.com
No comments:
Post a Comment